RPG Life Sciences Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from RPG Life Sciences Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹59Over the last 3 years, every ₹100 of reported profit came with ₹59 of operating cash.
Lower than 79% of Healthcare companies in India.
Self-Funding Ratio
1.3×Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.
Higher than 50% of Healthcare companies in India.
Cash Locked Ratio
₹17For every ₹100 of sales, ₹17 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹9 tied up three years earlier.
Less money tied up than 64% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹25Sales grew 38% in 3 years; of every extra ₹100 of sales, ₹25 became extra profit.
Higher than 70% of Healthcare companies in India.
Asset Productivity Ratio
+38% / +89%In 3 years sales changed by +38% while total assets changed by +89%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
8.5×Debt due within a year is covered 8.5 times by its yearly operating cash.
Higher than 74% of Healthcare companies in India.
Cash Cushion Ratio
+6%Cash, after subtracting all debt, equals 6% of its market value (net cash).
Higher than 83% of Healthcare companies in India.
Tangible Assets Ratio
99%Of every ₹100 the company owns, ₹99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 61% of Healthcare companies in India.
Tangible Net Worth Ratio
99%Of every ₹100 of net worth, ₹99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 64% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
RPG Life Sciences Limited owes ₹0.24 for every ₹1 it owns. Net profit fell 37% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
36.2Investors pay ₹36.2 for every ₹1 of RPG Life Sciences Limited's yearly profit, higher than 51% of Healthcare companies in India.
P/B ratio
7.16The share price is 7.16 times RPG Life Sciences Limited's book value per share, higher than 73% of Healthcare companies in India.
Market cap
₹4,333 CrThe total market value of all of RPG Life Sciences Limited's shares at today's price (share price × number of shares), smaller than 52% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹605 CrWhat RPG Life Sciences Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹366.01Net worth divided by the number of shares. The share price of ₹2,620 is 7.2 times this, which is the P/B above.
Return on equity (ROE)
19.8%RPG Life Sciences Limited earned 19.8% on its shareholders' money over the last year, higher than 80% of Healthcare companies in India.
Owes vs Owns
0.24×RPG Life Sciences Limited owes ₹0.24 for every ₹1 it owns (low), lower than 76% of Healthcare companies in India.
Dividend yield
0.88%RPG Life Sciences Limited pays 0.88% of its share price as dividends a year, higher than 77% of dividend-paying Healthcare companies in India.
Revenue growth
+8%Revenue rose 8% in the year to Mar 2026, and grew 11% a year on average over 3 years.
Profit growth
-37%Net profit fell 37% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Profit margin
16.4%RPG Life Sciences Limited keeps ₹16 of every ₹100 of revenue as net profit.
Cash quality
0.5×Cash from RPG Life Sciences Limited's business was 0.5× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
142.3×RPG Life Sciences Limited's operating profit covered its interest costs 142.3 times in the year to Mar 2026.
Cash vs debt
Net cashRPG Life Sciences Limited held ₹254 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is RPG Life Sciences Limited's P/E ratio?
Investors pay ₹36.2 for every ₹1 of RPG Life Sciences Limited's yearly profit, higher than 51% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For RPG Life Sciences Limited: ₹4,333 Cr ÷ ₹605 Cr (31 Mar 2026) = 7.2.
What is RPG Life Sciences Limited's return on equity?
RPG Life Sciences Limited earned 19.8% on its shareholders' money over the last year, higher than 80% of Healthcare companies in India.
How much does RPG Life Sciences Limited owe compared with what it owns?
RPG Life Sciences Limited owes ₹0.24 for every ₹1 it owns (low), lower than 76% of Healthcare companies in India.
Does RPG Life Sciences Limited pay a dividend?
Yes. RPG Life Sciences Limited pays 0.88% of its share price as dividends a year, higher than 77% of dividend-paying Healthcare companies in India.
Is RPG Life Sciences Limited's revenue growing?
Revenue rose 8% in the year to Mar 2026, and grew 11% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.